Ligand · SLC
SLC · Seleno-captopril
SLC, Seleno-captopril (C9 H13 N O3 Se, 262.2 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the ligands found with it.
- Component
- SLC
- Formula
- C9 H13 N O3 Se
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
SLC in 4 structures; the first of them:
- 2YDM · Structural characterization of angiotensin-I converting enzyme in complex with a selenium… · SLC A1626 · binds GLN281, HIS353, ALA354, HIS383, GLU384, HIS387, GLU411, PHE457 and 4 more
- 3ZQZ · Crystal structure of ance in complex with a selenium analogue of captopril · SLC A1010 · binds GLN265, HIS337, ALA338, THR364, HIS367, GLU368, HIS371, PHE441 and 4 more
- 2YDM · Structural characterization of angiotensin-I converting enzyme in complex with a selenium… · SLC A1626 · binds GLN281, HIS353, ALA354, HIS383, GLU384, HIS387, GLU411, PHE457 and 4 more
- 3ZQZ · Crystal structure of ance in complex with a selenium analogue of captopril · SLC A1010 · binds GLN265, HIS337, ALA338, THR364, HIS367, GLU368, HIS371, PHE441 and 4 more
Residues it binds most
HIS 4, TYR 4, GLU 4, ALA 4, GLN 4, LYS 4, PHE 4, THR 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.